Tercica Inc Watch

from 10-Q 9 pages May 21, 2008 Thorsten Von Stein Svp & Chief Medical Officer Tercica, Inc. 2000 Sierra Point Pkwy., Suite 400 Brisbane, Ca 94005 Re: Amendment to Offer Letter Dear Thorsten: Effective as of May 19, 2008, Tercica Agrees to Amend That Certain Offer Letter, Dated as of December 3, 2004, With Respect to the Following Paragraph and Its Terms: 1

from 10-Q 9 pages May 21, 2008 Andrew J. Grethlein Svp, Pharmaceutical Operations Tercica, Inc. 2000 Sierra Point Pkwy., Suite 400 Brisbane, Ca 94005 Re: Amendment to Offer Letter Dear Andy: Effective as of May 19, 2008, Tercica Agrees to Amend That Certain Offer Letter, Dated as of March 5, 2003, With Respect to the Following Paragraph and Its Terms

from 10-Q 1 page June 20, 2008 Ross G. Clark, PH.D. C/O Tercica, Inc. 2000 Sierra Point Parkway Suite 400 Brisbane, Ca 94005 Dear Ross: In Appreciation for All of Your Efforts on Behalf of Tercica, Inc., the Compensation Committee of the Board of Directors of Tercica, Inc. Has Approved an Amendment Pertaining to All of Your Currently Outstanding Unvested Tercica Stock Options and Restricted Stock Units

from 10-Q 2 pages Tercica, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane, California 94005 Re: First Option Event-Aghd/Other in the Combination Product Development and Commercialization Agreement to Whom It May Concern

from SC 13D/A 24 pages July 22, 2008 Tercica, Inc. Ipsen, S.A. and Suraypharm Common Stock Purchase Agreement Contents

from 8-K 24 pages July 22, 2008 Tercica, Inc. Ipsen, S.A. and Suraypharm Common Stock Purchase Agreement Contents

from SC 13D/A 15 pages June 4, 2008 Beaufour Ipsen Pharma, S.A.S. Tribeca Acquisition Corporation and the Stockholder Named Herein Voting Agreement

from 8-K 23 pages Tercica, Inc. Amended and Restated 2004 Stock Plan Adopted by the Board on February 26, 2008 Approved by the Stockholders on May 20, 2008 Section 1 Background and Purpose of the Plan

from 10-Q 2 pages This Letter Is Formal Notification That Pursuant to Your Offer Letter or Employment Agreement as the Case May Be, or Under the Company’s 2004 Stock Option Plan, When the Vesting of Your Stock Options Is Accelerated Due to a Change of Control, the Vesting of Your Rsus Will Be Similarly (I.E., as Regards Percent of Unvested) Accelerated. for Any Rsus Subject to a Deferral Election (I.E., Chosen by You), the Delivery of Your Accelerated Vested Shares Will Be Governed by the Terms of Your Rsu Agreement and Deferral Election Agreement. if You Have Any Questions, Please Do Not Hesitate to Contact Me. Very Truly Yours, Stephen N. Rosenfield Executive Vice President of Legal Affairs Schedule of Executive Officer Receipents John A. Scarlett, M.D. Ross G. Clark, PH.D. Richard A. King Ajay Bansal Stephen N. Rosenfield Thorsten Von Stein, M.D., PH.D. Andrew J. Grethlein, PH.D. Susan Wong

from 10-Q 1 page 2008 Compensation Information for Executive Officers

from 10-Q 12 pages Tercica, Inc. Restricted Stock Unit Grant Notice

from 10-Q 21 pages Tercica, Inc. 2004 Stock Plan Amended by the Board on September 6, 2006 Amended by the Board on February 26, 2008 Section 1 Background and Purpose of the Plan

from 10-K 17 pages Registration Rights Agreement

from 10-K 37 pages October 13, 2006 Tercica, Inc., Ipsen, S.A. and Suraypharm Affiliation Agreement Contents

from 10-Q 34 pages Development and Supply Agreement

from 10-Q 3 pages Tercica, Inc. Amendment No. 1 to Registration Rights Agreement

from 10-Q 26 pages July 9, 2007 Tercica, Inc. Ipsen, S.A. and Suraypharm Common Stock Purchase Agreement Contents

from 10-Q 28 pages Tercica, Inc. Second Amended and Restated Investors’ Rights Agreement

from 10-Q 1 page August 1, 2007 Richard King Re: Amendment to Offer Letter Dear Richard,

from 10-Q 19 pages Agreement